The mechanism by which drugs that target nucleic acids cause neurotoxicity is not well described. We characterized the neurotoxicity of Hoechst 33342 (bis-benzimide), a common cell permeable nuclear dye, in primary neuronal cultures. The mechanism of cell death was not apoptotic, as death is rapid, not accompanied by typical nuclear morphological changes, and is insensitive to inhibitors of transcription, translation and caspase activity. In addition, free-radical scavenging agents failed to attenuate cell death, and damage was not accompanied by mitochondrial dysfunction. Neuronal processes of cells exposed to Hoechst 33342 display dramatic fragmentation prior to cell death. When this compound was applied selectively to the distal axons of sympathetic neurons grown in compartmented cultures, the distal axons were destroyed. However, the proximal processes present in the cell body compartment were spared, demonstrating direct axonal toxicity rather than a remote effect of nuclear dysfunction. Other cell-permeable nucleic acid binding dyes similarly caused rapid dendritic and axonal toxicity. The hypothesis that these nucleic acid binding dyes target RNA localized to dendrites and axons is supported by observations that RNaseV1 induced similar, rapid neurite fragmentation. We conclude that the neurotoxic effects of nucleic acid binding compounds are mediated, at least in part, by direct neurite injury, which does not require involvement of the cell body and nucleus.
A large variety of pharmaceuticals have neurological sideeffects and cause neuronal damage. Yet, in most cases, the precise mechanisms of how these diverse compounds cause neuronal injury remain elusive. Compounds which interact with nucleic acids or nucleic acid metabolism frequently affect the nervous system. For example, the chemotherapeutic agent cytosine arabinoside causes confusion, seizures, and cerebellar dysfunction (Resar et al. 1993) . Several drugs that are used for cancer are associated with peripheral neuropathies, including chorambucil (Druker et al. 1989) , isofosfamide (Patel et al. 1994; Frisk et al. 2001) , cis-platin (Ozols and Young 1985) , and etoposide (Imrie et al. 1994) . Finally, dideoxy nucleoside analogues used for the treatment of HIV commonly result in peripheral neuropathy (Dubinsky et al. 1989; Dalakas 2001) .
These drugs are useful clinically because they target DNA synthesis, which is crucial for the growth of tumor cells and viral replication. Cytosine arabinoside is a nucleotide analogue which inhibits DNA synthesis (Slapak et al. 1985) . Chlorambucil and isofosfamide are alkylating agents (Kundu et al. 1994; Povirk and Shuker 1994; Fleming 1997) which are capable of modifying DNA and inhibiting DNA replication and transcription. Cis-platin directly binds to DNA and is thought to target DNA synthesis (Wang and Lippard 2005) . Etoposide inhibits DNA topoisomerase II, which is crucial for DNA synthesis and repair (Meresse et al. 2004) . Finally, HIV dideoxynucleosides impair reverse transcriptase, and therefore inhibit replication of the virus (De Clercq 2002) . It is widely accepted that these agents impair normal stability and/or replication of DNA, resulting in cell cycle disruption, apoptosis or inhibition of viral replication. However, in post-mitotic neurons, the mechanism of action of these agents in causing cellular damage is unclear, as these cells do not depend on DNA replication for survival. Several toxic mechanisms of action of have been proposed, including direct inhibition of DNA stability resulting in programmed cell death via multiple pathways (Park et al. 1998; Stefanis et al. 1999 ). Yet other studies have suggested neurotoxic compounds influence novel, nonnuclear biochemical pathways (Wallace and Johnson 1989; Martin et al. 1990 ). Nucleoside analogues have been shown to inhibit mitochondrial DNA synthesis (Cui et al. 1997) which may result in axonal energy failure and neurite dysfunction. In addition, recent studies of DRG neurons exposed to dideoxy drugs demonstrate neurite damage as a result of mitochondrial dysfunction on a timescale much faster than could be accounted for by mitochondrial DNA damage (Keswani et al. 2003) , implicating non-nucleic acid mitochondrial toxicity. Overall, given the chemical diversity of these compounds and the multifactorial susceptibility of neurons, it is expected that the neurological side-effects of the many drugs in use are a result of multiple, diverse mechanisms.
This study demonstrates an additional mechanism by which nucleic acid binding compounds induce neuronal injury. We report the neurotoxic properties of the nucleic acid binding agent Hoechst 33342, a cell-permeable dye used to label live cell nuclei. Curiously, in contrast to the slower actions of genotoxic compounds in non-neuronal cells, Hoechst 33342 induces extremely rapid morphological changes in neurites marked by fragmentation and blebbing of axons and dendrites. We find that Hoechst 33342 mediates toxicity through non-nuclear actions and further demonstrate that a variety of other nucleic binding agents mediate similar rapid neuronal damage. The morphological changes seen with nucleic acid binding compounds is mimicked by treatment with RNaseV1, suggesting that RNA may be an essential component of neurite homeostasis and that neuronal damage through nucleic acid binding drugs could be mediated by actions on neurite RNA.
Materials and methods

Cell culture
All animals were handled in accordance with established national and institutional guidelines under the auspices of the animal care and use committee. HEK293A cells (Qbiogene, Irvine, CA, USA) were grown as described in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (Xu et al. 2003) . Mouse cortical cultures were prepared from E18 embryos and plated on poly D-lysine-treated dishes in neurobasal/B27 media using established protocols (Brewer 1995; Xu et al. 2003) . Immunohistochemical analysis has demonstrated that our cultures are more than 99% neuronal. Experiments shown were performed on immature neurons (days in vitro 3-5) prior to the onset of glutamate sensitivity. Cells were transfected with pEGFP plasmids from Clontech (San Jose, CA, USA) using Lipofectamine 2000 (Xu et al. 2003) . For viability studies, cells were usually pretreated with DNaseI (10-20 lg/mL for 2-6 h followed by media replacement) before addition of drugs to decrease background counting of dead cells in the culture. Livedead assays were performed using calcein AM and propidium iodide (PI) (Molecular Probes, Eugene, OR, USA); live cells metabolize calcein AM and fluoresce green, while dead cells fluoresce red because of PI access to the nucleus. Cells were imaged and photographed using an inverted Nikon TE200 equipped with a Spot RT digital camera. For time-course studies, cells were grown in HEPES-buffered media in an enclosed chamber on the microscope stage which was heated to 37°C. At least four different high powered (40 ·) fields were photographed, and then manually counted. Morphological changes in axons and dendrites (collectively referred to as neurites) were scored in a blinded fashion. A neuron was scored as exhibiting significant neuritic damage if more than one axonal or dendritic process had at least three regions of distinct blebbing or fragmentation along its length. In general, if a neuron had one damaged neurite, almost all of the processes, including dendrites and axons, were damaged. Nuclear morphology was also analyzed blinded using established criteria for apoptosis (Stefanis et al. 1999) . Data from all groups represent at least three wells of cultures and each experiment was performed three times to validate consistency between cultures.
Culture of sympathetic neurons in compartmented Campenot chambers Compartmented Campenot chambers were set up as described by Senger and Campenot (1997) . Briefly, 35-mm dishes were precoated with a layer of ammoniated rat tail collagen (0.75 mg/mL), followed by a layer of air-dried rat tail collagen supplemented with laminin (10 lg/mL). Three-compartmented Teflon dividers (Camp10, Tyler Research Instruments, Edmonton, AB, Canada) were seated on top of parallel tracks scratched in the collagen substrate with a pin rake (Tyler Research Instruments) and secured in place with silicone vacuum grease (Dow Corning, Huntington Beach, CA, USA). Integrity of the grease seals was assessed by placing culture medium into the side chambers only and incubating the chambers overnight in a 37°C incubator. Only chambers that did not leak were used in subsequent experiments. Medium was removed from side compartments and dissociated sympathetic neurons were plated in the center compartment in serum-free medium (Dulbecco's modified Eagle's medium/F12 with N2 supplement) containing nerve growth factor (100 ng/mL, Harlan Bioproducts, Madison, WI, USA). Sympathetic neurons were dissociated from the superior cervical ganglia of embryonic day 21 or post-natal day 1-2 Holtzmann rats (Harlan SpragueDawley, Rockford, IL, USA) according to previously described methods (Lein and Higgins 1989) . The next day the integrity of the seals between the compartments was reconfirmed by checking for leakage from the compartment containing the cell suspension into the adjacent compartments. Culture medium then was added to the compartments not containing cells of those culture dishes exhibiting intact seals between compartments, and cytosine-arabinoside (1 lM) was added to the medium in the compartment containing the cell bodies for 48 h to eliminate non-neuronal cells. After axons had extended through the grease seals into the adjacent compartments (5-7 d after plating), nerve growth factor was withdrawn from the compartment containing cell bodies but was maintained in the adjacent compartments to encourage growth of axons into the adjacent compartments and to eliminate neurons that had failed to extend axons through the grease seals. Experiments were initiated when there was significant neurite outgrowth in the adjacent compartments (10-14 d after plating).
Reagents
All drugs and chemicals were obtained from Sigma (St Louis, MO, USA), unless noted. Cell culture media were from Invitrogen (Carlsbad, CA, USA). Fluorescent probes were obtained from Molecular Probes. Biochemical grade RNaseV1 and purified tRNA were purchased from Ambion (Austin, TX, USA).
Statistical analyses
Data is presented from representative experiments, which were repeated at least three times. Standard error bars are shown which represent cell counts from three wells of cells treated in identical fashion.
Results
Cell death induced by nucleic acid binding dyes
Hoechst 33342 is a commonly used nucleic acid binding dye, which is highly cell permeable. Because of these properties, it has been used to label nuclei of live cells for cell sorting, tracking, and for analysis of nuclear morphology. Although Hoechst 33342 has been shown to induce apoptosis in HL-60 and BC3H-1 cells (Zhang and Kiechle 1997; Zhang et al. 1999) , its effect on primary neurons has not been characterized. In initial experiments, we found that Hoechst 33342 causes rapid concentration-dependent toxicity in cultured murine cortical neurons (Figs 1a and c). Neurons were significantly more sensitive to the toxic effects of Hoechst 33342 relative to non-neuronal cells (Figs 1b and d) .
Non-apoptotic mechanism of Hoechst 33342 cell death Several lines of evidence suggest that Hoechst 33342 may cause neuronal cell death via apoptosis. First, Hoechst has been shown to cause apoptosis in HL-60, BC3H-1 myocytes, H4-II-E-C3 rat hepatoma cells, HT-114 melanoma cells, and human skin fibroblasts (Zhang and Kiechle 1997; Zhang et al. 1999; Kiechle 2002) . Second, Hoechst 33342 not only binds to minor grooves in DNA, but also inhibits topoisomerase I, and other agents that inhibit this enzyme, including camptothecin, cause neuronal apoptosis (Morris and Geller 1996) . To determine if Hoechst 33342 similarly induces apoptosis in cultured cortical neurons, we compared the effects of Hoechst 33342 and camptothecin on nuclear morphology.
Nuclei of cortical neurons treated with camptothecin for 24 h appeared shrunken, blebbed and fragmented ( Fig. 2a) , which is characteristic of cells undergoing apoptosis (Stefanis 1999) . In contrast, nuclei of cortical neurons treated with Hoechst 33342 for 24 h appeared round and intact ( Fig. 2b ) and did not exhibit the morphological characteristics of nuclei undergoing programmed cell death. Actinomycin D and cycloheximide, inhibitors of RNA and protein synthesis, respectively, failed to attenuate Hoechst 33342-induced cell death (Figs 2c and d ). In addition, DNA isolated from cells treated with Hoechst 33342 did not demonstrate fragmentation, as seen with camptothecin treatment (Fig. 2e) , although there was a slight apparent change in mobility in Hoechst-treated DNA, which could have been the result of infrequent nicking of DNA or of a change in mobility induced by dye intercalation. In total, we found no evidence that Hoechst 33342 acts by programmed cell death as determined by a variety of established markers of apoptosis.
Morphological effects of nuclei acid binding dyes in neurites
To investigate the morphological effects of Hoechst 33342 on cortical neurons, we transfected neurons with a green fluorescent protein (GFP) expression plasmid prior to adding the drug. This enabled us to visualize the effects of Hoechst 33342 over time on individual cells. Nearly all neurons displayed striking morphological changes marked by progressive blebbing and fragmentation of the neurite (Fig. 3a) . Hoechst 33342 caused similar morphological changes in neurons grown in low-density cultures that were loaded with the fluorescent vital dye calcein AM (not shown). Hoechst 33342 does not induce these rapid morphological changes by inhibition of topoisomerase I, as camptothecin failed to induce similar morphologic changes (Fig. 3b) . The response was rapid, as all cells displayed abnormal morphology after 30 min of 30 lM Hoechst 33342 (Fig. 3c) .
Next, we examined whether other cell permeable nucleic acid binding compounds exhibited similar properties as Hoechst 33342. Indeed, a large number of dyes were able to induce visible neurite morphological changes in a rapid time frame at micromolar concentrations (Fig. 4) . Of note, nonpermeant dyes such as propidium iodide failed to elicit rapid neurite damage (not shown).
Hoechst 33342 death mechanism is independent of free radical formation and mitochondrial stress Neurons are extremely sensitive to free radical-induced cell death. We therefore tested whether free radical scavengers could attenuate cell death induced by Hoechst 33342. Free radical-mediated mechanisms appear to be unlikely as scavengers such as phenyl-tert-butylnitrone (Gould and Bickford 1994; Sturgess et al. 2000; Fig. 5) failed to attenuate Hoechst 33342 toxicity.
Another important determinant of neurite integrity is mitochondrial stability. We thus assessed whether the morphological changes seen in response to Hoechst 33342 could be linked to mitochondrial toxicity (Fig. 6 ). To determine whether mitochondrial stress could play a role in Hoechst 33342 neurite toxicity, we loaded cells with tetramethylrhodamine methylester (TMRM) (Nieminen et al. 1995; Ward et al. 2000) to determine whether loss of mitochondrial membrane potentials preceded neurite fragmentation. It has been previously reported that acute exposures to Hoechst 33342 cause a transient mitochondrial depolarization in HL-60 cells (Chen et al. 2004) . Similarly, we observed a 50% reduction in TMRM fluorescence in cortical neurons 15 min after adding H33342 at 60 lM, but TMRM fluorescence returned to control levels within 30 min (unpublished data). However, mitochondrial potentials were unaffected at early time points when exposed to Hoechst 33342 at lower concentrations (15 lM) that cause neurite fragmentation. In fact, the mitochondrial signal persisted long after initial signs of neurite fragmentation and blebbing, suggesting that mitochondrial injury does not play a significant role in neurite instability. Therefore, progressive changes to the mitochondria, at least at this level, do not appear to correlate with neurite damage. Analysis of the TMRM fluorescence in neurites was compared with cell body fluorescence to discern potential differences in neurite versus cell body mitochondria (not shown). This analysis failed to demonstrate evidence of neurite mitochondrial dysfunction prior to appearance of morphological changes.
Role of excitotoxicity in Hoechst 33342-induced neurite changes Neurites can be damaged by excitotoxic injury and display characteristic changes that are remarkably similar to those induced by Hoechst 33342, with fragmentation, swelling and blebbing seen within minutes of NMDA application (Park et al. 1996) . Although the neurons used in this study were immature and resistant to glutamate toxicity, we performed experiments to determine if blocking excitotoxic pathways was sufficient to attenuate Hoechst 33342 toxicity (Fig. 7) . Excitotoxicity depends on activation of voltage-sensitive sodium channels and calcium influx through both voltage-sensitive calcium changes and glutamate receptors (Hasbani et al. 1998) . As shown in Fig. 7 , blocking voltage-gated sodium channels with TTX (1 lM), did not alter the toxic effects of Hoechst 33342 on neurite morphology. Similarly, sequestration of extracellular calcium by EDTA, or blocking of calcium influx through glutamate receptors by the glutamate receptor antagonists MK801 and NBQX failed to block the morphological changes seen with Hoechst 33342.
Toxicity of Hoechst 33342 on isolated axons
The rapid toxicity to neurites could involve direct action on the neurite, and/or an indirect action on the cell body, which then signals to the axonal and dendritic processes. To distinguish between these mechanisms, we examined the effect of Hoechst 33342 on sympathetic neurons grown in compartmented cultures (Senger and Campenot 1997) . Addition of Hoechst 33342 to one of the two compartments containing distal axons resulted in progressive degeneration of axonal morphology within that compartment only (Figs 8a and b). Axonal fragmentation was not observed in the compartment containing cell bodies and proximal processes, nor was it observed in the second compartment containing distal axons that were not exposed directly to Hoechst 33342. Similarly, degeneration of processes was also seen when the drug was added to the chamber containing cell bodies and proximal axons; however, distal axons not in direct contact with drugs maintained normal morphology (Fig. 8c) . These results demonstrated that Hoechst 33342 causes local, direct toxic effects on axons in vitro, and that this toxicity is not dependent on interactions with nuclear DNA. 
Toxicity of RNaseV1 on neurites
RNA is present in the neurites of neurons (Knowles et al. 1996; Job and Eberwine 2001) . RNA frequently adopts secondary structure involving inter-and intramolecular base pairing, which confers it with common chemical properties with DNA. Consequently, RNA and DNA share affinity for most nucleic acid binding drugs, including Hoechst 33342 dyes (Wilson et al. 1993; Dassonneville et al. 1997 ) and the SYTO compounds (Molecular Probes) (Knowles et al. 1996) . Therefore, the neurotoxicity of nucleic acid binding compounds could potentially be mediated by interactions with RNA, rather than DNA. As most nucleic acid probes do not distinguish between RNA and DNA, we assessed the effect of RNaseV, an endonuclease that specifically targets double-stranded RNA (Lockard and Kumar 1981; Lowman and Draper 1986 ), on neurite morphology. As demonstrated in Fig. 9(a and b) , incubation of this enzyme with cortical neurons causes rapid morphological changes in neurites that are comparable with those observed with Hoechst 33342 over the same time period (results with RNaseV1 are quantified in Fig. 9e ). The enzymatic action of RNase can be inhibited by heparin or tRNA (Mahalakshmi et al. 2000) , and pre-incubation of cortical cultures with either heparin or tRNA (Mahalakshmi et al. 2000) completely blocked the RNaseV1-induced changes in neurite morphology, suggesting that the cytotoxic actions of RNase were mediated by its RNA degradation function (Figs 9c and d ; results are quantified in Fig. 9f ). In addition, heat treatment of RNaseV1 strongly inhibited its toxic effects in cortical neurons (Fig. 9g) , suggesting that an enzymatic component rather than a small chemical contaminant from the preparations, mediated RNaseV1 neurotoxicity.
We next attempted to test whether RNaseV1 was crossing the cell membrane to disrupt RNA. When neurons were treated with RNaseV1, there was an immediate decrease in the amount of total RNA extracted from treated cells at 30 min (Fig. 9h) . There was no further decrease in the amount of RNA for 4 h. However, membrane permeability to propidium iodide was seen in parallel cultures only at 4 h and beyond (Fig. 9i) . These data suggest that RNaseV1 is capable of crossing the cell membrane and digesting intracellular RNA, and that this precedes the onset of cell death.
Discussion
Our studies demonstrate unique neurotoxic properties of nucleic acid binding dyes. Although nucleic acid binding dyes have been developed specifically for their nuclear Fig. 1 ) and live cells remaining were counted using calcein AM fluorescence.
properties, the neurotoxic properties of these compounds do not appear to involve apoptosis and surprisingly cause direct local neurotoxic effects in neurites via mechanisms that do not involve the cell body or nucleus. Similar neurite damage was observed for a large family of cell permeable nucleic acid binding agents, suggesting a common molecular pathway. Park et al. (1996) have previously demonstrated the acute morphological changes induced by glutamate in mature cortical cultures. Glutamate-induced changes in neurite morphology are strikingly similar to those we observe in immature cultures exposed to nucleic acid binding dyes. In contrast to these studies, we used immature cortical cultures in which excitotoxicity is not a significant mechanism of death. Therefore, it is not surprising that the mechanism by which these neurons die in response to Hoechst 33342 appears not to involve glutamate toxicity, voltage-sensitive sodium channels, or extracellular calcium, suggesting a neurotoxic mechanism distinct from glutamate-induced toxicity that results in a grossly similar phenotype. Also, in contrast to studies with glutamate, Hoechst 33342 toxicity involves both axons and dendrites, whereas excitotoxininduced neuritic damage has been described only in dendrites (Park et al. 1996) . We have shown similar toxic effects of several of these nucleic acid binding compounds in mature, glutamate-sensitive cortical and hippocampal cultures (unpublished data). Combined with our findings that peripheral neurons also demonstrate sensitivity to these agents, we conclude that our results appear to be generalized to multiple neuronal types.
What could account for the exquisite sensitivity of neurites to damage by nucleic acid binding compounds? Although non-nucleic acid-dependent mechanisms are possible, the common dramatic effect of numerous structurally diverse nucleic acid binding agents suggests that these compounds act on neurons through nucleic acid binding. We therefore consider two classes of mechanisms: those involving DNA versus those targeting RNA.
Nuclear DNA
The most direct evidence arguing against the hypothesis that nucleic acid binding drugs cause neurotoxicity via interactions with nuclear DNA are the experiments using sympathetic neurons grown in compartmented Campenot chambers. Rapid axonal damage was seen only with direct application of nucleic acid binding compounds and did not require application to the nucleus. While there are great similarities in the temporal, quantitative and qualitative nature of the neurite damage observed in response to Hoechst 33342 between sympathetic and cortical neurons in our study, one cannot rule out the possibility that nuclear DNA is involved in Hoechst 33342-mediated cortical neuronal injury. However, this seems unlikely as neurite blebbing and fragmentation is obvious within 10 min of Hoechst application. This amount of time seems insufficient to allow the sequence of events that would have to occur if DNA were the primary target, e.g. diffusion of the dye through the plasma membrane and nuclear membrane into the nucleus, signaling within the nucleus, and signal transduction from the nucleus to the neurite several hundred microns away. Further evidence arguing against the involvement of nuclear DNA in Hoechst 33342 neurotoxicity comes from experiments (not shown) demonstrating that staining of the nucleus with these nuclear acid binding dyes is not detectable until at least 10 min after dye application.
Mitochondrial DNA Another possible target of nucleic acid binding dyes is mitochondrial DNA. Mitochondria play essential roles in producing the energy required for normal neurite homeostasis. It seems logical that inhibition of mitochondrial DNA could impair energy metabolism, leading to rapid neurite dysfunction. However, the rapidity of Hoechst 33342-induced changes in neurite morphology is inconsistent with energy failure because of mitochondrial genomic inhibition, which would require rapid turnover of mitochondrial gene products. In addition, our time-course studies indicate that, although acute exposure to high concentrations of Hoechst (60 lM) causes a transient decrease in mitochondrial potential, there is no long-term progressive disruption which parallels neurite instability. Furthermore, acute exposure to lower Hoechst concentrations that cause neurite fragmentation (15 lM) do not decrease mitochondrial potential. This strongly suggests that mitochondria are functional during the time that nucleic acid binding compounds are disrupting neurites, although we cannot rule out the possibility that a transient depolarization of mitochondria plays a destabilizing role.
RNA
We present evidence that RNA may be an important target of nucleic acid binding compounds. RNA within neurites has been described recently, and is thought to be transported long distances based on cis-acting sequences encoded mostly in the 3¢ untranslated region. Local translation of this RNA has been demonstrated in dendrites (reviewed Steward 2003) and in axons (reviewed Piper 2004) , and plays a role in growth cone collapse (Wu 2005) . Ribosomal RNA is also localized to neurites and is undoubtedly required for translation of this RNA. While some of this RNA appears to be localized in foci that are traceable with dyes such as SYTO14 (Knowles et al. 1996) , a large number of studies have also demonstrated broadly distributed localization depending on the RNA species (Mohr 2000; Wu 2005 ). Therefore, current information suggests that as a whole, RNA is diffusely localized throughout the neurite. This matches well with the diffuse distribution of neurite breakpoints we describe.
Most nucleic acid binding compounds are able to bind to RNA as well as DNA, some with affinities greater for RNA (Wilson et al. 1993; Knowles et al. 1996; Dassonneville et al. 1997) . Many of these agents selectively bind to doublestranded RNA with significantly higher affinity compared with single-stranded RNA. Experiments demonstrating that RNaseV1 causes neurotoxic effects comparable with those induced by Hoechst 33342 suggest that dsRNA is the principal target in Hoechst 33342 neurotoxicity and indicate that dsRNA may play an important role in neurite homeostasis. Two observations suggest that the neurotoxic effects of RNaseV1 are mediated by its RNA degrading function: (i) known inhibitors of RNaseV1 attenuate its neurotoxic effects on cortical neurons; and (ii) RNaseV1 neurotoxicity is sensitive to heat. We cannot yet exclude the possibility that minor contaminants within the RNaseV1 preparation used in these studies that are also sensititve to heparin, tRNA, and heat inactivation may be responsible for the enzyme's neurotoxic activity. Phospholipase A2 from cobra venom can contaminate preparation of RNaseV1; however, heparin increases the activity of phospholipases (Patel et al. 1997 ) and phospholipase A2 is not known to be affected by tRNA. Heparin is known to inhibit complement-activating toxins from cobra venom (Edens et al. 1994) ; however, our experiments were performed in serum-free media, which lack complement. We postulate that the RNaseV1 protein is cell permeable or that the RNA target that mediates neurite morphology is extracellular. The former possibility is more likely, and not necessarily surprising as many proteins, particularly in venom extracts (the source of the RNaseV1 used in our studies) are capable of crossing the plasma membrane. This is supported in experiments showing that RNaseV1 diminishes ribosomal RNA content within cells in a time course that precedes membrane permeability to propidium iodide, a molecule much smaller than RNaseV1 which is commonly used as a marker of cell death. Conclusive demonstration that RNaseV1 is able to cross the cytoplasmic membrane will require development of specific antisera which are not yet available.
The selectivity of RNaseV1 for double-stranded RNA in vitro suggests that the putative RNA target in neurons has a significant secondary structure. The possible known RNA targets include tRNA, rRNA, mRNA, ribonuclear proteins and microRNAs. Although microRNAs are single stranded, processing of microRNA precursors requires double-stranded RNA (Hutvagner and Zamore 2002) . Targeting tRNA or rRNA would be predicted to impair protein synthesis within neurites. Because transient inhibition of protein synthesis by cycloheximide fails to cause neurite fragmentation, it is more likely that mRNA or structural RNAs that are not integrally involved in protein synthesis are targeted by RNaseV1 and the nucleic acid binding dyes. The rapidity of morphological changes seen in our experiments also strongly suggests that RNA may play a structural role within the neurite, as opposed to a role in protein synthesis. Recent data has demonstrated that spreading initiation centers, novel cytoskeletal structures present early in cell spreading, are highly enriched in RNA binding proteins and ribosomal RNA (de Hoog et al. 2004) . Taken together with our experiments, these studies suggest a novel role for RNA in cytoskeletal maintenance and dynamic modulation.
We note that this mechanism does not apply to all classes of drugs that interfere with nucleic acid functions (e.g. topoisomerase inhibitors or dideoxy nucleoside analogues). However, considering the wide variety of potential RNA structures that could exist in neurites, it is possible that even drugs without a known affinity for nucleic acids, could act on neurons through specific RNA binding. For example, AZT, a specific inhibitor of HIV reverse transcriptase which causes neuropathy has been shown to bind to RNA (Ahmed Ouameur et al. 2004) . In further support that RNA could be a general target of neurotoxic compounds, we note that several drugs, including streptomycin (Wallace and Schroeder 1998) , spectinomycin (Thom and Prescott 1997) , and tobramycin (Hermann and Westhof 1999) , have been shown to bind to specific RNA sequences with high affinity.
In conclusion, nucleic acid binding agent-induced neurotoxicity through non-nuclear paths provides an alternative mechanism for neurite damage which is independent of excitotoxicity and free radicals and is possibly mediated by interactions with RNA. The precise mechanism of damage to neurites may have important implications regarding the cause and treatment of neuropathies associated with nucleic acid binding drugs. Finally, from a practical point of view, these studies indicate that cell permeable nucleic acid binding agents should be used with caution in neuronal culture studies.
